Results 271 to 280 of about 1,231,622 (330)

Molecular Prostheticsand CFTR Modulators AdditivelyIncrease Secretory HCO₃^– Flux in CysticFibrosis Airway Epithelia

Nohemy Celis (22462516), Danforth P. Miller (22462519), Thomas E. Tarara (22462522), Jeffry G. Weers (22462525), Ian M. Thornell (8909801), Michael J. Welsh (22462528), Martin D. Burke (1280013)   +6 more
openalex   +1 more source

Qualitative study exploring the views and perceptions of parents/carers of young children with CF regarding the introduction of CFTR modulator therapy (The REVEAL study; PaRents pErspectiVEs of KAftrio in chiLdren aged 2-5). [PDF]

BMJ Open Respir Res
Davies SH, Wade F, Fogg H, Walsh A, Southern KW.   +4 more
europepmc   +1 more source

Changes in vitamins and trace elements after initiation of highly effective CFTR modulator therapy in children and adults with cystic fibrosis - a real-life insight. [PDF]

Mol Cell Pediatr
Fabricius D, Knieling T, Zurmuehl N, Makedon L, Freihorst J, Schmidt H, Bode S.   +6 more
europepmc   +1 more source

Lung transplant referral for individuals with cystic fibrosis: Cystic Fibrosis Foundation consensus guidelines [PDF]

, 2019
CF Lung Transplant Referral Guidelines Committee,, Dunitz, Jordan M, Faro, Albert, Gray, Alice L, Hempstead, Sarah E, Lucy, Amy, McKone, Edward F, Pilewski, Joseph M, Ramos, Kathleen J, Rosenbluth, Daniel B, Smith, Patrick J, Tallarico, Erin   +11 more
core   +1 more source

Raman Spectroscopy and Cystic Fibrosis Disease: An Alternative Potential Tool for Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulator Response Differentiation-A Pilot Study Based on Serum Samples. [PDF]

Molecules
Acri G, Testagrossa B, Lucanto MC, Cristadoro S, Pellegrino S, Ruello E, Costa S.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Unmasking hereditary hemochromatosis with CFTR modulator therapy

Journal of Clinical Images and Medical Case Reports, 2022
Cystic Fibrosis (CF) is a genetic condition affecting the ability to excrete chloride, resulting in multi-system organ damage. Liver disease is one co-morbidity that affects 20-40% of people with CF. This case describes a 16-year-old male with CF (F508Del and Q493X mutations) who was started one lexacaftor/tezacaftor/ifacaftortriple CF Transmembrane ...
Richard Wong, DO, Roberts, Abigail, Michelle Condren, PharmD   +2 more
openaire   +1 more source

The psychological implications and health risks of cystic fibrosis pre- and post- CFTR modulator therapy

Chronic Illness, 2022
Objectives Cystic Fibrosis (CF) care is entering a period of personalised medicine with the emergence of CF transmembrane conductance regulator (CFTR) modulator therapies. Anecdotally individuals are reporting life-changing effects of modulator therapies,
R. Keyte, S. Kauser, M. Mantzios, H. Egan   +3 more
semanticscholar   +1 more source